PDCD1 and melanoma: Even though the present study showed that NLR could potentially predict OS, it failed to indicate the predictive value of NLR for ORR and PFS in anti-PD-1 therapy, which indicated that dMMR mCRC might be distinct with melanoma or NSCLC.